Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 18, 2026
DataAggregated Company Financials
Companies7
- 7D-6.3%
- 3M-12.9%
- 1Y-22.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 6.3%, driven by Oxford Nanopore Technologies declining 6.7%. In contrast, Oxford BioDynamics has gained 25%. The industry has fallen 22% in the last year. Looking forward, earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 18 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1178.4x | -7.9x | 4x |
| Mon, 15 Jun 2026 | UK£1.3b | UK£323.0m | -UK£166,018,254.00 | 1243.9x | -8.1x | 4.1x |
| Wed, 13 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.1x | 4.3x |
| Fri, 10 Apr 2026 | UK£1.2b | UK£323.0m | -UK£156,192,254.00 | 9.6x | -7.9x | 3.8x |
| Sun, 08 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.7x | -8.7x | 4.3x |
| Tue, 03 Feb 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -10.9x | 5.7x |
| Thu, 01 Jan 2026 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.1x | -9x | 4.7x |
| Sat, 29 Nov 2025 | UK£1.6b | UK£303.9m | -UK£162,910,254.00 | 7.3x | -9.7x | 5.2x |
| Mon, 27 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -9.8x | 5.3x |
| Wed, 24 Sep 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 10.7x | -10.7x | 5.7x |
| Fri, 22 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Sun, 20 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -10.1x | 5.6x |
| Tue, 17 Jun 2025 | UK£1.5b | UK£319.3m | -UK£190,728,209.20 | 6.7x | -8x | 4.8x |
| Thu, 15 May 2025 | UK£1.7b | UK£313.3m | -UK£193,053,608.90 | 11.3x | -8.7x | 5.4x |
| Sat, 12 Apr 2025 | UK£1.5b | UK£315.4m | -UK£186,148,089.85 | 6.3x | -8.3x | 4.9x |
| Mon, 10 Mar 2025 | UK£1.5b | UK£321.0m | -UK£182,103,508.40 | 6.7x | -8.4x | 4.8x |
| Wed, 05 Feb 2025 | UK£2.0b | UK£306.8m | -UK£195,470,674.80 | 7.4x | -10.1x | 6.4x |
| Fri, 03 Jan 2025 | UK£1.9b | UK£307.2m | -UK£195,722,613.60 | 7.4x | -9.5x | 6x |
| Sun, 01 Dec 2024 | UK£2.1b | UK£306.3m | -UK£194,748,532.32 | 8.5x | -10.7x | 6.8x |
| Tue, 29 Oct 2024 | UK£2.0b | UK£304.7m | -UK£192,540,796.00 | 10.3x | -10.2x | 6.5x |
| Thu, 26 Sep 2024 | UK£2.1b | UK£303.8m | -UK£191,680,478.40 | 11.3x | -11.1x | 7x |
| Sat, 24 Aug 2024 | UK£1.8b | UK£295.5m | -UK£188,218,412.70 | 12.4x | -9.8x | 6.2x |
| Mon, 22 Jul 2024 | UK£1.7b | UK£295.3m | -UK£189,720,861.18 | 12.9x | -8.9x | 5.7x |
| Wed, 19 Jun 2024 | UK£1.6b | UK£295.7m | -UK£189,891,194.97 | 11.5x | -8.2x | 5.3x |
| Fri, 17 May 2024 | UK£1.7b | UK£294.7m | -UK£187,538,224.43 | 7747.2x | -8.8x | 5.6x |
| Sun, 14 Apr 2024 | UK£1.6b | UK£317.8m | -UK£178,579,491.35 | 12.2x | -9x | 5.1x |
| Tue, 12 Mar 2024 | UK£1.9b | UK£292.9m | -UK£212,419,688.67 | 7175.5x | -9.2x | 6.6x |
| Thu, 08 Feb 2024 | UK£2.1b | UK£285.9m | -UK£189,314,296.57 | 7108.3x | -11.1x | 7.3x |
| Sat, 06 Jan 2024 | UK£3.1b | UK£450.0m | -UK£173,987,191.00 | 62.1x | -17.9x | 6.9x |
| Mon, 04 Dec 2023 | UK£3.1b | UK£455.2m | -UK£168,866,409.00 | 50.7x | -18.2x | 6.7x |
| Wed, 01 Nov 2023 | UK£2.9b | UK£458.7m | -UK£165,659,039.00 | 45.7x | -17.8x | 6.4x |
| Fri, 29 Sep 2023 | UK£2.9b | UK£450.3m | -UK£168,184,771.00 | 67.5x | -17.5x | 6.5x |
| Sun, 27 Aug 2023 | UK£3.1b | UK£476.5m | -UK£126,784,080.00 | 70.6x | -24.2x | 6.4x |
| Tue, 25 Jul 2023 | UK£3.5b | UK£476.3m | -UK£124,547,274.00 | 69.6x | -27.9x | 7.3x |
Price to Earnings Ratio
-27.9x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.03% | |
| Healthcare | -1.25% | |
| Life Sciences | -6.27% | |
| Clinical Research and Equipment | -6.27% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OBD Oxford BioDynamics | UK£0.0013 | 25.0% +UK£1.1m | -76.2% | PS4.5x | |
| PRM Proteome Sciences | UK£0.019 | 11.8% +UK£701.4k | -37.5% | PS1.8x | |
| PYC Physiomics | UK£0.0053 | 10.5% +UK£226.6k | 10.5% | PS2.4x |
